Kardigan, Inc. - Common Stock (NQ:KARD)

15.52 +1.66 (+11.98%)

Delayed Quote Updated: 4:00 PM EST, Nov 6, 2026 Add to My Watchlist

Price and Volume

Volume	406,632
Open	14.00
Bid (Size)	13.00 (300)
Ask (Size)	16.60 (100)
Prev. Close	13.86
Today's Range	13.57 - 15.56
52wk Range	12.23 - 27.00
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Kardigan Extends Phase 2 Ataciguat Trial Assessment, Targets 2027 Results ↗

Today 11:14 EST

Kardigan (NASDAQ:KARD) said its phase 2 trial of investigational drug ataciguat in aortic stenosis is fully enrolled and that it will assess the study’s primary endpoint at 48 weeks, rather than 24...

Via MarketBeat

Kardigan Completes Enrollment in Phase 2b KATALYST-AV Trial and Announces New Evidence Supporting Patient Selection and Endpoints for the Evaluation of Ataciguat in Aortic Stenosis

November 06, 2026

From Kardigan, Inc.

Via Business Wire

Performance

52-Week Range 42.5% below 52-week high

15.52

12.2352W Low 27.0052W High

1 Week 1.7% below 1-week high

13.531W Low 15.791W High

Kardigan, Inc. - Common Stock (KARD) traded between $12.23 and $27.00 over the past 52 weeks and last traded at $15.52, 42.5% below its 52-week high. Over the past week it ranged between $13.53 and $15.79.

Past 12 Months

+9.2%

+9.3%

-26.4%

-29.5%

1W +$1.31

1M +$1.32

3M -$5.56

6M -$6.48

YTD -$6.48

1Y -$6.48

KARD was -29.5% over the past year, -29.5% over six months, -29.5% year to date, +9.2% in the last week.